UK Markets closed

Scholar Rock Holding Corporation (SRRK)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
11.94-0.59 (-4.71%)
At close: 04:00PM EST
11.94 0.00 (0.00%)
After hours: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous close12.53
Open12.42
Bid7.01 x 800
Ask12.55 x 800
Day's range11.91 - 12.44
52-week range4.32 - 21.17
Volume106,858
Avg. volume267,809
Market cap616.861M
Beta (5Y monthly)0.63
PE ratio (TTM)N/A
EPS (TTM)-2.81
Earnings date06 Mar 2023 - 10 Mar 2023
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est26.71
  • Business Wire

    Scholar Rock Appoints Tracey M. Sacco as Chief Commercial Officer

    CAMBRIDGE, Mass., February 06, 2023--Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced the appointment of Tracey M. Sacco as Chief Commercial Officer. Ms. Sacco brings extensive biopharmaceutical industry experience, including product launch and global commercial strategy. At Scholar Rock, she will build and lead all commercial functions, including s

  • Business Wire

    Scholar Rock Provides Corporate Update and Highlights Priorities for 2023

    CAMBRIDGE, Mass., January 09, 2023--Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today provided recent corporate updates and highlighted upcoming priorities for its pipeline programs in 2023.

  • Business Wire

    Scholar Rock to Present at the 41st Annual J.P. Morgan Healthcare Conference

    CAMBRIDGE, Mass., January 03, 2023--Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that management will present at the J.P. Morgan 41st Annual Healthcare Conference on Tuesday, January 10, 2023, at 1:30 p.m. PT (4:30 p.m. ET).